Our goal in this project is to understand the ontogeny and regulation of endogenous opioid systems and their contribution to developmental and analgesic processes. We will integrate morphological, genetic, and behavioral approaches to elucidate several aspects of opioid peptide expression, maturation and function. We will continue to delineate the prenatal expression patterns for gene families involved in processing propeptides including opioids. We will first determine the fetal expression patterns for novel carboxypeptidase-like and prohormone convertase genes. We will also compare the prenatal expression of PC2 and its chaperone 7B2, combined with analysis of PC2 maturation by immunoblotting, to define the relationship between 7B2 expression and the maturation of PC2 activity. Morphologic and genetic approaches will be used to elucidate specific aspects of PAM function. The relationship between sites of PAM expression and a specific substrate/receptor system in the developing nervous system will be examined; then gene-targeted mice deficient in PAM will be produced to identify required developmental roles for this locus. We will continue to examine the role of endogenous opioid peptides in three paradigms. First, we will determine whether sensitivity to exogenous opioid ligands is altered in enkephalin and beta-EP/enk KO mice and whether there are accompanying changes in the expression or activity of opioid system components. We will evaluate the contributions of enkephalin and beta-EP/enk KO mice p-EP peptides to stress-induced analgesia by analyzing single- and double-KO mice. Finally, we will produce gene-targeted mice null for dynorphin, which will be examined for development abnormalities, changes in analgesic responses, and alterations in opioid system gene expression. Our last goal will be to investigate genetically the role of the D2 and D3 receptors in pituitary and brain development. We will determine whether prenatal changes in D3 expression accompany a gene-targeted mutation of D2 and whether the D2 mutant mice, alone or in combination with D3 mutations, exhibit alterations in intermediate pituitary (IL) differentiation and maturation. Solution and in situ hybridization will determine whether changes in IL POMC expression accompany either KO and whether the change in neonatal IL glucocorticoid response, thought to be dopamine mediated, is altered in D2 or D2/D3 mutants. Taken together, these studies will elucidate multiple aspects of fetal prohormone processing while using and establishing genetic models to investigate the roles of endogenous opioid ligands in analgesia and mechanisms of plasticity that underlie drug abuse.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA008622-18
Application #
6175733
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Riddle, Robert D
Project Start
1986-08-01
Project End
2003-03-31
Budget Start
2000-04-15
Budget End
2001-03-31
Support Year
18
Fiscal Year
2000
Total Cost
$244,031
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Neurosciences
Type
Schools of Medicine
DUNS #
622146454
City
Piscataway
State
NJ
Country
United States
Zip Code
08854
Gomes, Ivone; Aryal, Dipendra K; Wardman, Jonathan H et al. (2013) GPR171 is a hypothalamic G protein-coupled receptor for BigLEN, a neuropeptide involved in feeding. Proc Natl Acad Sci U S A 110:16211-6
Morgan, Daniel J; Wei, Suwen; Gomes, Ivone et al. (2010) The propeptide precursor proSAAS is involved in fetal neuropeptide processing and body weight regulation. J Neurochem 113:1275-84
Lena, I; Bradshaw, S; Pintar, J et al. (2008) Adaptive changes in the expression of central opioid receptors in mice lacking the dopamine D2 receptor gene. Neuroscience 153:773-88
Lee, Sang-Nam; Peng, Bonnie; Desjardins, Roxane et al. (2007) Strain-specific steroidal control of pituitary function. J Endocrinol 192:515-25
Czyzyk, Traci A; Ning, Yun; Hsu, Ming-Sing et al. (2005) Deletion of peptide amidation enzymatic activity leads to edema and embryonic lethality in the mouse. Dev Biol 287:301-13
Peinado, Juan R; Laurent, Virginie; Lee, Sang-Nam et al. (2005) Strain-dependent influences on the hypothalamo-pituitary-adrenal axis profoundly affect the 7B2 and PC2 null phenotypes. Endocrinology 146:3438-44
Morgan, Daniel J; Mzhavia, Nino; Peng, Bonnie et al. (2005) Embryonic gene expression and pro-protein processing of proSAAS during rodent development. J Neurochem 93:1454-62
Snyder, S E; Peng, B; Pintar, J E et al. (2003) Expression of VGF mRNA in developing neuroendocrine and endocrine tissues. J Endocrinol 179:227-35
Nitsche, Joshua F; Schuller, Alwin G P; King, Michael A et al. (2002) Genetic dissociation of opiate tolerance and physical dependence in delta-opioid receptor-1 and preproenkephalin knock-out mice. J Neurosci 22:10906-13
Laurent, V; Kimble, A; Peng, B et al. (2002) Mortality in 7B2 null mice can be rescued by adrenalectomy: involvement of dopamine in ACTH hypersecretion. Proc Natl Acad Sci U S A 99:3087-92

Showing the most recent 10 out of 22 publications